Navigation Links
Wyeth Reports Earnings Results for the 2008 Third Quarter and First Nine Months
Date:10/22/2008

.68

Average Number of Common

Shares Outstanding during

Each Period - Basic 1,332,744 1,343,036 1,333,542 1,343,897

Diluted Earnings per

Share $0.84 $0.84 $2.56 $2.63

Average Number of Common

Shares Outstanding during

Each Period - Diluted 1,356,909 1,372,145 1,358,902 1,376,505

See Notes to Results of Operations.

Results of Operations - As Adjusted

Wyeth has prepared the following presentation of its results of operations for the three and nine months ended September 30, 2008 and 2007, adjusted to exclude charges, which are considered certain significant items during the 2008 and 2007 third quarter and first nine months.

The comparative results of operations - as adjusted are as follows:

(In thousands except per share amounts)

(UNAUDITED) - AS ADJUSTED

Three Months Ended Nine Months Ended

9/30/2008 9/30/2007 9/30/2008 9/30/2007

Net Revenue $5,829,582 $5,619,536 $17,485,589 $16,636,272

Cost of Goods Sold 1,528,702 1,506,381 4,661,083 4,439,890

Selling, General and

Administrative Expenses 1,569,629 1,664,801 4,922,217 4,844,341

Research and Development

Expenses 793,362 798,434 2,443,685 2,374,079

Interest (Income)

Expense, Net 12,953 (39,622) 4,182 (73,440)

Other (Income)

Expense, Net 101,878 (61,416) 18,371 (251,748)

Income before Income Taxes 1,823,058 1,750,958 5,436,051 5,303,150

Provision for Income Taxes 604,811 519,053 1,718,673 1,552,120

Net Income $1,
'/>"/>

SOURCE Wyeth
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14

Related biology technology :

1. Wyeth Wins Philadelphia Diet Drug Trial Involving Claim of PPH
2. Wyeth Announces Increase in Common Stock Dividend
3. Retrospective Analysis of Phase 3 Data Suggest Wyeths Investigational Compound Bazedoxifene/Conjugated Estrogens Comparable to Placebo on Incidence of Abnormal Mammograms
4. Wyeth Sets Webcast And Conference Call for 2008 Third Quarter Earnings
5. Cyprus and Ireland Add Wyeths 7-Valent Pneumococcal Conjugate Vaccine (PCV7) to Their National Immunisation Schedules
6. Wyeth Names Daniel J. McIntyre Vice President, Corporate Communications
7. Wyeth and Impax Announce Final Settlement of Effexor XR Patent Suit
8. Wyeths Motion to Overturn Punitive Damages Award Granted by Arkansas Court
9. Wyeth Announces Bernard Poussot Assumes Chairman of the Board Position
10. Wyeth Declares Common and Preferred Stock Dividends
11. Wyeth Pharmaceuticals Announces Organizational Change
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/27/2015)... MA (PRWEB) May 27, 2015 The ... is directing, via its wholly owned subsidiary, Anelixis ... potential treatment for ALS that targets the innate immune ... ALS Therapy Development Institute received from the 2014 social ... The entire sum of $4 million raised directly by ...
(Date:5/27/2015)... OAKS, Calif. , May 27, 2015  Ceres, ... has been awarded a U.S. patent for a genetic ... in areas such as research, product development and plant ... in regulating key biosynthetic processes that are the target ... offer other seed companies a commercial license to the ...
(Date:5/26/2015)... USA (PRWEB) May 26, 2015 The ... partnership with the Max Planck Society establishing ... Quantum Photonics. The center will link two of the ... and will be only the third Max Planck Centre ... the international society for optics and photonics, was ...
(Date:5/26/2015)... and HILDEN, Germany ... QIAGEN N.V. (NASDAQ: QGEN ; Frankfurt Prime ... its QIAGEN Clinical Insight ® (QCI™) bioinformatics ... to interpret and report on genomic variants identified ... applications for the bioinformatics platform are in oncology, ...
Breaking Biology Technology:Ice Bucket Challenge Advances Antibody Toward Clinical Trial for ALS 2Ice Bucket Challenge Advances Antibody Toward Clinical Trial for ALS 3Ceres Awarded Patent for Innovation in Soybean 2Ceres Awarded Patent for Innovation in Soybean 3Third Max Planck Centre in North America Inaugurated at University of Ottawa 2Third Max Planck Centre in North America Inaugurated at University of Ottawa 3QIAGEN Launches Clinical Bioinformatics Platform for Next-Generation Sequencing 2QIAGEN Launches Clinical Bioinformatics Platform for Next-Generation Sequencing 3QIAGEN Launches Clinical Bioinformatics Platform for Next-Generation Sequencing 4QIAGEN Launches Clinical Bioinformatics Platform for Next-Generation Sequencing 5
... Pa., Aug. 24 MEDRAD, Inc. has signed a ... to study the impact of automated Fluoro-deoxy-glucose (FDG) administration ... procedures. Clinicians at Moffitt Cancer Center in Tampa, ... measure and infuse patient-specific FDG doses while industrial engineers ...
... , , SAN DIEGO, Aug. ... today announced that Mark Booth has joined the Company as ... of commercial and business development experience to Orexigen. Most ... (TPNA) where he presided over the commercial, medical and scientific ...
... , KVISTGAARD, Denmark, August ... that the US authorities have initiated,negotiations for a ... the,IMVAMUNE(R) smallpox vaccine. This potential new project will ... Advanced Research and,Development Authority) contract for the procurement ...
Cached Biology Technology:MEDRAD Partners with the University of South Florida and Moffitt Cancer Center to Study Workflow and Process Improvements in PET Imaging 2MEDRAD Partners with the University of South Florida and Moffitt Cancer Center to Study Workflow and Process Improvements in PET Imaging 3MEDRAD Partners with the University of South Florida and Moffitt Cancer Center to Study Workflow and Process Improvements in PET Imaging 4Orexigen(R) Therapeutics Appoints Mark Booth Chief Commercial Officer 2Bavarian Nordic in Negotiations With the US Authorities for the Further Development of IMVAMUNE(R) 2
(Date:4/17/2015)... 2015 Increasing adoption ... advancement to drive biometric systems market in ... According to a recently released TechSci ... ", biometric systems market in Saudi ... at CAGR of over 22% through 2020. The ...
(Date:4/13/2015)... 2015 According to a ... Market Forecast & Opportunities, 2020", the global biometrics market ... 14% till 2020. The biometrics market is garnering ... and review of biometric management systems. The constant ... with greater efficiency, are resulting in increasing installation ...
(Date:4/9/2015)... 9, 2015 Synaptics Inc. (NASDAQ: SYNA ), ... that it will report financial results for the third ... after the close of market. The company will host ... 2:00 p.m. PT (5:00 p.m. ET), during which management ... on the live call, analysts and investors should dial ...
Breaking Biology News(10 mins):Saudi Arabia Biometric Systems Market to Grow at 22% Through 2020, Says TechSci Research 2Saudi Arabia Biometric Systems Market to Grow at 22% Through 2020, Says TechSci Research 3Global Biometrics Market to Cross US$ 21 Billion by 2020: TechSci Research 2Synaptics to Report Third Quarter Results on April 23 2
... canister for campers a real testIn a scene reminiscent ... puts the product's durability to the test, grizzly bears ... designed for backpackers a real beating, according to the ... best efforts, the bears could not open the canister, ...
... Rice scientists replace pricey solvents with cheap processing ... of fluorescent quantum dots, scientists at Rice University ... pricey solvents used in quantum dot synthesis with ... plants. , Rice's study, which was conducted under ...
... pricey solvents with cheap processing fluidsIn an important ... dots, scientists at Rice University have developed a ... in quantum dot synthesis with cheaper oils that ... study, which was conducted under the auspices of ...
Cached Biology News:Bronx Zoo bears are new Samsonite gorillas 2The right drug at the right time 2The right drug at the right time 3Method slashes quantum dot costs by 80 percent 2Method slashes quantum dot costs by 80 percent 3
...
Alexa Fluor 647 anti-mouse Qa-2...
...
... for hunting and analyzing the rare ... EST sequencing projects, microarrays, functional screenings ... developed for normalization of cDNA enriched ... directional cloning. While most normalization methods ...
Biology Products: